Additionally, the diagnostic utility of fibrinogen may be enhanced when combined with other tumor markers, such as carcinoembryonic antigen and prealbumin, potentially improving diagnostic performance in CRC [44]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.